IL-4 and IL-13 inhibition in atopic dermatitis, a review

被引:0
|
作者
Matsunaga, Matthew [1 ]
Yamauchi, Paul [2 ,3 ]
机构
[1] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[2] UCLA, David Geffen Sch Med, Dermatol Inst, Santa Monica, CA USA
[3] Skin Care Ctr, Santa Monica, CA USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
3690
引用
收藏
页码:AB87 / AB87
页数:1
相关论文
共 50 条
  • [1] IL-4 and IL-13 Inhibition in Atopic Dermatitis
    Matsunaga, Matthew C.
    Yamauchi, Paul S.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (08) : 925 - 929
  • [2] The IL-4, IL-13 and IL-31 pathways in atopic dermatitis
    Dubin, Celina
    Del Duca, Ester
    Guttman-Yassky, Emma
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (08) : 835 - 852
  • [3] Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis
    Tazawa, T
    Sugiura, H
    Sugiura, Y
    Uehara, M
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2004, 295 (11) : 459 - 464
  • [4] Atopic Dermatitis: Biologikum inhibits IL-4 and IL-13 Signaling Pathways
    Walter, Monika
    ALLERGO JOURNAL, 2020, 29 (06) : 80 - 80
  • [5] Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis
    Takahiro Tazawa
    Hisashi Sugiura
    Yasuo Sugiura
    Masami Uehara
    Archives of Dermatological Research, 2004, 295 : 459 - 464
  • [6] New treatments for atopic dermatitis targeting beyond IL-4/IL-13 cytokines
    Renert-Yuval, Yael
    Guttman-Yassky, Emma
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 124 (01) : 28 - 35
  • [7] Exploring the Potential of IL-4 and IL-13 Plasma Levels as Biomarkers in Atopic Dermatitis
    Mitroi, George G.
    Plesea, Elena Leocadia
    Mitroi, George F.
    Mitroi, Mihaela Roxana
    Neagoe, Carmen Daniela
    Ianosi, Simona Laura
    LIFE-BASEL, 2024, 14 (03):
  • [8] Inhibition of IL-4 and IL-13 with an IL-4 mutein (Aeroderm) protects against flares in atopic eczema
    Groves, R. W.
    Wilbraham, D.
    Fuller, R.
    Longphre, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S54 - S54
  • [9] Different effects of combined blockade of IL-4/IL-13 and selective inhibition of IL-13 in in vitro model systems for atopic dermatitis with allergen stimulated lymphocytes
    Honstein, T.
    Evers, S.
    Roesner, L. M.
    Zeitvogel, J.
    Werfel, T.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2021, 141 (05) : S3 - S3
  • [10] Commonality of the IL-4/IL-13 pathway in atopic diseases
    Gandhi, Namita A.
    Pirozzi, Gianluca
    Graham, Neil M. H.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (05) : 425 - 437